Michael Frost

ECRI Institute — United States

Medicine · Health Sciences

28h-index9.0kcitations99works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberous Sclerosis Complex Research(50), Epilepsy research and treatment(10), Opioid Use Disorder Treatment(9), Renal cell carcinoma treatment(8), Polyomavirus and related diseases(8)

Publications96 total

Neurodevelopmental Outcomes From the PREVeNT Trial
Pediatric Neurology·2025
Dosing to Effect With Weekly and Monthly Subcutaneous and Daily Sublingual Buprenorphine: Post Hoc Analysis of a Phase 3 Clinical Trial
Journal of Addiction Medicine·2025· 1 citedOpen Access
Anaesthesia for Plastic Surgery in Children
Cambridge University Press eBooks·2025
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial
Pediatric Neurology·2024· 7 citedOpen Access
Bystander-application of a novel nasal swab optimized for drug delivery is safe and non-traumatic for the general population
Drug and Alcohol Dependence·2024
Drug Resistant Epilepsy in Tuberous Sclerosis Complex is Associated with Tsc2 Genotype: More Findings from the Prevent Trial
SSRN Electronic Journal·2024Open Access
Acute Isolated Thrombocytopenia Secondary to Meloxicam Use: A Case Report
Cureus·2022· 1 citedOpen Access
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
Pediatric Neurology·2021· 649 citedOpen Access
Buprenorphine maintenance treatment in patients with opioid use disorder diagnosed with COVID-19
Journal of Opioid Management·2020· 1 cited
Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study
Pediatric Neurology·2020· 58 cited
The effects of buprenorphine depot implants on patient sleep and quality of life: findings from a mixed-methods pilot trial
Addiction Research & Theory·2019· 3 cited
Enhanced Tumor Regression and Immune Cell Infiltration by Inhaled Submicron Particle Paclitaxel in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer (NSCLC)
2019
Long‐term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out‐patients with opioid use disorder
Addiction·2019· 103 citedOpen Access
Language and behavioral outcomes of treatment with pulse-dose prednisone for electrical status epilepticus in sleep (ESES)
Epilepsy & Behavior·2019· 18 cited
Everolimus for treatment-refractory seizures in TSC
Neurology Clinical Practice·2018· 104 citedOpen Access
PMH74 - QUALITY OF LIFE ACCORDING TO TEMPORAL ILLICIT OPIOID USE AND RESPONDER RATE IN ADULTS RECEIVING BUPRENORPHINE DEPOT INJECTIONS (CAM2038) TO TREAT OPIOID USE DISORDER IN A 48-WEEK OPEN LABEL STUDY
Value in Health·2018
Buprenorphine Implant Removal 7 Years Postinsertion: A Case Report
Journal of Addiction Medicine·2018· 4 cited
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2
Nephrology Dialysis Transplantation·2018· 56 citedOpen Access
Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey
Journal of Patient-Reported Outcomes·2018· 11 citedOpen Access
Economic burden, work, and school productivity in individuals with tuberous sclerosis and their families
Journal of Medical Economics·2018· 29 cited
page 1 of 5Next →

Frequent Co-authors

John J. Bissler(14), Steven Sparagana(12), J.C. Kingswood(12), Darcy A. Krueger(11), Klemens Budde(11), Е. Д. Белоусова(11), Hope Northrup(10), David Neal Franz(10), Petrus J. de Vries(10), Elizabeth A. Thiele(9), E. Martina Bebin(9), James W. Wheless(9), Sergiusz Jóźwiak(9), Bernard A. Zonnenberg(9), Noah Berkowitz(9), Matthias Sauter(8), Paolo Curatolo(7), Joyce Y. Wu(7), Julian R. Sampson(6), Bruce R. Korf(6)